Influence of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) on ventricular fibrillation induced by coronary occlusion.
D000813:Anilides / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications*; D004285:Dogs; D008697:Methane / Q000627:therapeutic use; D013451:Sulfonic Acids / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000209:etiology*
D000813:Anilides; D000889:Anti-Arrhythmia Agents; D013451:Sulfonic Acids; D008697:Methane